Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver

Eun Jeong Jung, Sung Won Kwon, Byung Hwa Jung, Seon Hee Oh, Byung Hoon Lee

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Orotic acid (OA), an intermediate in pyrimidine metabolism, has been used for a variety of purposes, such as dietary supplements. Although it is well documented that OA induces fatty liver in a species-specific manner, the precise molecular mechanisms remain unclear. The present study investigated the role of the adenosine monophosphate-activated protein kinase (AMPK)-sterol regulatory element-binding protein-1 (SREBP-1) pathway in the OAinduced fatty liver. Treatment with OA suppressed the phosphorylation of AMPK via proteasomal degradation of upstream kinase LKB1 and induced activation of SREBP-1 in both human hepatoma cell lines and primary rat hepatocytes. OA-induced SREBP-1 transcriptional activity was suppressed by cotreatment with aminoimidazole carboxamide ribonucleotide (AICAR) or metformin, or by overexpression of constitutively active AMPK (CA-AMPK) in the human hepatoma cell line. Importantly, in vivo data corroborated these results. Feeding 1% OA with diet decreased the phosphorylation of AMPK and increased the maturation of SREBP-1 and the expression of SREBP-responsive genes in the rat liver. OA-induced lipid accumulation was also completely inhibited by rapamycin. Mouse hepatocytes and mice were resistant to OA-induced lipogenesis because of little if any response in AMPK and downstream effectors. In conclusion, OA induces hepatic lipogenesis, mediated predominantly by the AMPK/SREBP-1 pathway in rat hepatocytes and human hepatoma cell lines.

Original languageEnglish (US)
Pages (from-to)1617-1625
Number of pages9
JournalJournal of Lipid Research
Volume52
Issue number9
DOIs
StatePublished - Sep 2011

Fingerprint

Sterol Regulatory Element Binding Protein 1
Orotic Acid
Fatty Liver
Adenosine Monophosphate
Liver
Protein Kinases
Rats
Hepatocytes
Hepatocellular Carcinoma
Lipogenesis
Phosphorylation
Cells
Cell Line
Dietary supplements
Metformin
Sirolimus
Nutrition
Dietary Supplements
Metabolism
Phosphotransferases

Keywords

  • Adenosine monophosphate-activated protein kinase
  • Lipids
  • Pharmacology
  • Sterol regulatory element-binding protein-1
  • Toxicology

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Endocrinology

Cite this

Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver. / Jung, Eun Jeong; Kwon, Sung Won; Jung, Byung Hwa; Oh, Seon Hee; Lee, Byung Hoon.

In: Journal of Lipid Research, Vol. 52, No. 9, 09.2011, p. 1617-1625.

Research output: Contribution to journalArticle

Jung, Eun Jeong ; Kwon, Sung Won ; Jung, Byung Hwa ; Oh, Seon Hee ; Lee, Byung Hoon. / Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver. In: Journal of Lipid Research. 2011 ; Vol. 52, No. 9. pp. 1617-1625.
@article{57a8c934dcee4fb4b7160df4ea918055,
title = "Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver",
abstract = "Orotic acid (OA), an intermediate in pyrimidine metabolism, has been used for a variety of purposes, such as dietary supplements. Although it is well documented that OA induces fatty liver in a species-specific manner, the precise molecular mechanisms remain unclear. The present study investigated the role of the adenosine monophosphate-activated protein kinase (AMPK)-sterol regulatory element-binding protein-1 (SREBP-1) pathway in the OAinduced fatty liver. Treatment with OA suppressed the phosphorylation of AMPK via proteasomal degradation of upstream kinase LKB1 and induced activation of SREBP-1 in both human hepatoma cell lines and primary rat hepatocytes. OA-induced SREBP-1 transcriptional activity was suppressed by cotreatment with aminoimidazole carboxamide ribonucleotide (AICAR) or metformin, or by overexpression of constitutively active AMPK (CA-AMPK) in the human hepatoma cell line. Importantly, in vivo data corroborated these results. Feeding 1{\%} OA with diet decreased the phosphorylation of AMPK and increased the maturation of SREBP-1 and the expression of SREBP-responsive genes in the rat liver. OA-induced lipid accumulation was also completely inhibited by rapamycin. Mouse hepatocytes and mice were resistant to OA-induced lipogenesis because of little if any response in AMPK and downstream effectors. In conclusion, OA induces hepatic lipogenesis, mediated predominantly by the AMPK/SREBP-1 pathway in rat hepatocytes and human hepatoma cell lines.",
keywords = "Adenosine monophosphate-activated protein kinase, Lipids, Pharmacology, Sterol regulatory element-binding protein-1, Toxicology",
author = "Jung, {Eun Jeong} and Kwon, {Sung Won} and Jung, {Byung Hwa} and Oh, {Seon Hee} and Lee, {Byung Hoon}",
year = "2011",
month = "9",
doi = "10.1194/jlr.M015263",
language = "English (US)",
volume = "52",
pages = "1617--1625",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "9",

}

TY - JOUR

T1 - Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver

AU - Jung, Eun Jeong

AU - Kwon, Sung Won

AU - Jung, Byung Hwa

AU - Oh, Seon Hee

AU - Lee, Byung Hoon

PY - 2011/9

Y1 - 2011/9

N2 - Orotic acid (OA), an intermediate in pyrimidine metabolism, has been used for a variety of purposes, such as dietary supplements. Although it is well documented that OA induces fatty liver in a species-specific manner, the precise molecular mechanisms remain unclear. The present study investigated the role of the adenosine monophosphate-activated protein kinase (AMPK)-sterol regulatory element-binding protein-1 (SREBP-1) pathway in the OAinduced fatty liver. Treatment with OA suppressed the phosphorylation of AMPK via proteasomal degradation of upstream kinase LKB1 and induced activation of SREBP-1 in both human hepatoma cell lines and primary rat hepatocytes. OA-induced SREBP-1 transcriptional activity was suppressed by cotreatment with aminoimidazole carboxamide ribonucleotide (AICAR) or metformin, or by overexpression of constitutively active AMPK (CA-AMPK) in the human hepatoma cell line. Importantly, in vivo data corroborated these results. Feeding 1% OA with diet decreased the phosphorylation of AMPK and increased the maturation of SREBP-1 and the expression of SREBP-responsive genes in the rat liver. OA-induced lipid accumulation was also completely inhibited by rapamycin. Mouse hepatocytes and mice were resistant to OA-induced lipogenesis because of little if any response in AMPK and downstream effectors. In conclusion, OA induces hepatic lipogenesis, mediated predominantly by the AMPK/SREBP-1 pathway in rat hepatocytes and human hepatoma cell lines.

AB - Orotic acid (OA), an intermediate in pyrimidine metabolism, has been used for a variety of purposes, such as dietary supplements. Although it is well documented that OA induces fatty liver in a species-specific manner, the precise molecular mechanisms remain unclear. The present study investigated the role of the adenosine monophosphate-activated protein kinase (AMPK)-sterol regulatory element-binding protein-1 (SREBP-1) pathway in the OAinduced fatty liver. Treatment with OA suppressed the phosphorylation of AMPK via proteasomal degradation of upstream kinase LKB1 and induced activation of SREBP-1 in both human hepatoma cell lines and primary rat hepatocytes. OA-induced SREBP-1 transcriptional activity was suppressed by cotreatment with aminoimidazole carboxamide ribonucleotide (AICAR) or metformin, or by overexpression of constitutively active AMPK (CA-AMPK) in the human hepatoma cell line. Importantly, in vivo data corroborated these results. Feeding 1% OA with diet decreased the phosphorylation of AMPK and increased the maturation of SREBP-1 and the expression of SREBP-responsive genes in the rat liver. OA-induced lipid accumulation was also completely inhibited by rapamycin. Mouse hepatocytes and mice were resistant to OA-induced lipogenesis because of little if any response in AMPK and downstream effectors. In conclusion, OA induces hepatic lipogenesis, mediated predominantly by the AMPK/SREBP-1 pathway in rat hepatocytes and human hepatoma cell lines.

KW - Adenosine monophosphate-activated protein kinase

KW - Lipids

KW - Pharmacology

KW - Sterol regulatory element-binding protein-1

KW - Toxicology

UR - http://www.scopus.com/inward/record.url?scp=80051820360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051820360&partnerID=8YFLogxK

U2 - 10.1194/jlr.M015263

DO - 10.1194/jlr.M015263

M3 - Article

C2 - 21757781

AN - SCOPUS:80051820360

VL - 52

SP - 1617

EP - 1625

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 9

ER -